TY - JOUR
T1 - Coronary Atherosclerosis in Athletes
T2 - Exploring the Role of Sporting Discipline
AU - Aengevaeren, Vincent L.
AU - Mosterd, A.
AU - Sharma, Sanjay
AU - Braber, Thijs L.
AU - Thompson, Paul D.
AU - Velthuis, Birgitta K.
AU - Eijsvogels, Thijs M.H.
N1 - Funding Information:
Please note: This work was supported by a grant from SPORTCOR, a Dutch national registry of sudden cardiac arrest in athletes, the Foundations “Wetenschappelijk Onderzoek Hart-en Vaatziekten” and “Bijstand Meander Medical Center” Amersfoort, the Röntgen Foundation Utrecht and Philips Healthcare. Drs. Aengevaeren and Eijsvogels are financially supported by grants from the Dutch Heart Foundation (#2017T088 and #2017T051, respectively). Dr. Thompson has received grant support from Sanofi, Regeneron, Esperion, Amarin, and Amgen; has served as a consultant for Amgen, Regeneron, Sanofi, and Esperion; has received speaker honoraria from Amarin, Sanofi, Regeneron, Amgen, and Kowa; and owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, Sarepta, Boston Scientific, and Myokardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Funding Information:
Please note: This work was supported by a grant from SPORTCOR, a Dutch national registry of sudden cardiac arrest in athletes, the Foundations “Wetenschappelijk Onderzoek Hart-en Vaatziekten” and “Bijstand Meander Medical Center” Amersfoort, the Röntgen Foundation Utrecht and Philips Healthcare. Drs. Aengevaeren and Eijsvogels are financially supported by grants from the Dutch Heart Foundation (#2017T088 and #2017T051, respectively). Dr. Thompson has received grant support from Sanofi, Regeneron, Esperion, Amarin, and Amgen; has served as a consultant for Amgen, Regeneron, Sanofi, and Esperion; has received speaker honoraria from Amarin, Sanofi, Regeneron, Amgen, and Kowa; and owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, Sarepta, Boston Scientific, and Myokardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2019/8/1
Y1 - 2019/8/1
UR - https://www.scopus.com/pages/publications/85069857551
U2 - 10.1016/j.jcmg.2019.01.002
DO - 10.1016/j.jcmg.2019.01.002
M3 - Letter
C2 - 30772217
AN - SCOPUS:85069857551
SN - 1936-878X
VL - 12
SP - 1587
EP - 1589
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
IS - 8
ER -